Localised and unresectable neuroblastoma in infants: Excellent outcome with primary chemotherapy

Medical and Pediatric Oncology

Volumn 36, Issue 1, 2001, Pages 247-250

  David, Kerstin ^a,b   Heiligtag, Sven ^a   Ollert, Markus W ^b   Teppke, Manfred ^a   Vogel, Carl Wilhelm ^b   Bredehorst, Reinhard ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

^b UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; VINCRISTINE;

BRAIN SCINTISCANNING; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHILD; CONFERENCE PAPER; DRUG EFFICACY; FEMALE; GENE AMPLIFICATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEUROBLASTOMA; OUTCOMES RESEARCH; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR LOCALIZATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOXORUBICIN; ETOPOSIDE; FEMALE; GENE AMPLIFICATION; GENES, MYC; HUMANS; INFANT; INFANT, NEWBORN; LIFE TABLES; MALE; NEOPLASM STAGING; NEUROBLASTOMA; POSTOPERATIVE COMPLICATIONS; RADIOTHERAPY, ADJUVANT; REMISSION INDUCTION; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; VINCRISTINE;

EID: 0035161768     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-911X(20010101)36:1<247::AID-MPO1061>3.0.CO;2-Z     Document Type: Conference Paper

References (14)

1. Factors influencing survival of children with non metastatic neuroblastoma
2. Neuroblastomes traités àl' Institut Gustave Roussy de 1975 à 1979. Cent soixante treize cas
3. Evaluation of the role of surgery in 130 patients with neuroblastoma
4. Localized resectable neuroblastoma: Results of the second study of the Italian Cooperative Group for Neuroblastoma
5. Influence of locoregional lymph nodes metastasis on prognosis in neuroblastoma
6. Improvement in survival after excision of primary tumour in Stage III neuroblastoma
7. Radical excision of primary tumour and lymph nodes in advanced neuroblastoma: Comparison with intensive chemotherapy
8. Stage III neuroblastoma over 1 year at diagnosis: Improved survival with intensive multimodality therapy including multiple alkylating agents
9. Localized but unresectable neuroblastoma: Treatment and outcome of 145 cases
10. Etoposide and carboplatin in neuroblastoma: A French Society of Pediatric Oncology Phase II Study
11. Revisions of the International Criteria for Neuroblastoma Diagnosis, Staging and Response to treatment
12. Unresectable localised neuroblastoma: Improved survival after primary chemotherapy including Carboplatin Etoposide
13. Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy
14. Localized neuroblastoma: N-Myc gene amplification is a major prognostic factor. Results of the French NBL 90 study